KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Interest Coverage Ratio (2023 - 2025)

Travere Therapeutics (TVTX) has disclosed Interest Coverage Ratio for 7 consecutive years, with 15.05 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 29.73% year-over-year to 15.05, compared with a TTM value of 5.87 through Dec 2025, up 79.69%, and an annual FY2025 reading of 5.87, up 79.69% over the prior year.
  • Interest Coverage Ratio was 15.05 for Q4 2025 at Travere Therapeutics, down from 8.9 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 8.9 in Q3 2025 and bottomed at 49.73 in Q1 2024.
  • Average Interest Coverage Ratio over 3 years is 21.17, with a median of 20.82 recorded in 2024.
  • Peak annual rise in Interest Coverage Ratio hit 144.03% in 2025, while the deepest fall reached 29.73% in 2025.
  • Year by year, Interest Coverage Ratio stood at 33.65 in 2023, then soared by 36.34% to 21.42 in 2024, then rose by 29.73% to 15.05 in 2025.
  • Business Quant data shows Interest Coverage Ratio for TVTX at 15.05 in Q4 2025, 8.9 in Q3 2025, and 4.44 in Q2 2025.